MMR Vaccine Target Achieved in England for the First Time
The number of eligible children receiving their first dose of the Measles, Mumps and Rubella vaccine (MMR1) by…
O4 Research is an innovative Contract Research Organisation (CRO), operating throughout the UK, Ireland and Europe wide, which provides dynamic integrated trial management solutions to the pharmaceutical, biotechnology and medical device industries.
Read MoreOur clients are able to benefit from our extensive experience in Phases II to IV clinical trials and observational/ non-interventional studies across a wide variety of therapeutic...
ServicesWe are a transparent partner who believes a collaborative approach holds the key to the success of our business and leads to a mutually respectful relationship with our clients. The inherent efficiencies of the O4 business model allow us to be commercially competitive by reducing the large overheads other large CROs incur, translating into significant savings for our clients.
Coming soon - Watch our animation to see what goes on behind the scenes at O4…
All of the latest news and event information from O4 Research
The number of eligible children receiving their first dose of the Measles, Mumps and Rubella vaccine (MMR1) by…
The Bradford Macula Centre, a part of Bradford Teaching Hospitals NHS Foundation Trust, was officially opened on 20th…
The 17th EURETINA Congress was recently held in Barcelona from 7th -10th September 2017, featuring World Retina Day…